Cercar
01/01/2022
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)
Gallego-Durán R., Albillos A., Ampuero J., Arechederra M., Bañares R., Blas-García A., Berná G., Caparrós E., Delgado T.C., Falcón-Pérez J.M., Francés R., Fernández-Barrena M.G., Graupera I., Iruzubieta P., Nevzorova Y.A., Nogueiras R., Macías R.I.R., Martín F., Sabio G., Soriano G., Vaquero J., Cubero F.J., Gracia-Sancho J.. Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH). Gastroenterologia y Hepatologia. 2022; 45(9)DOI:10.1016/j.gastrohep.2022.02.005. PMID:35248669. IF:1.900(Q4/10D).
01/01/2022
Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry
Calafat M., Mañosa M., Ricart E., Nos P., Iglesias-Flores E., Vera I., López-Sanromán A., Guardiola J., Taxonera C., Mínguez M., Martín-Arranz M.D., de Castro L., de Francisco R., Rivero M., Garcia-Planella E., Calvet X., García-López S., Márquez L., Gomollón F., Barrio J., Esteve M., Muñoz F., Gisbert J.P., Gutiérrez A., Hinojosa J., Argüelles-Arias F., Busquets D., Bujanda L., Pérez-Calle J.L., Sicilia B., Merino O., Martínez P., Bermejo F., Lorente R., Barreiro-De Acosta M., Rodríguez C., García-Sepulcre M.F., Monfort D., Cañete F., Domènech E.. Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry. Journal of Crohns & Colitis. 2022; 16(6)DOI:10.1093/ecco-jcc/jjab213. PMID:34864947. IF:8.000(Q1/2D).
01/01/2022
Baveno VII – Renewing consensus in portal hypertension
de Franchis R., Bosch J., Garcia-Tsao G., Reiberger T., Ripoll C., Abraldes J.G., Albillos A., Baiges A., Bajaj J., Bañares R., Barrufet M., Benajiba L., Berzigotti A., Bureau C., Calvaruso V., Cardenas A., D'Amico G., De Gottardi A., Dell'Era A., Escorsell A., Fallowfield J., Ferral H., Francque S., Gaba R., Garcia-Pagàn J.C., Genescà J., Rodrigues S.G., Gracia-Sancho J., Han G., Hernandez-Gea V., Jia J., Kiladjian J.J., Krag A., Laleman W., La Mura V., Lens S., Luo X., Mandorfer M., Murad S.D., Paradis V., Patch D., Piano S., Pinzani M., Plessier A., Primignani M., Procopet B., Rautou P.E., Rudler M., Sarin S.K., Schepis F., Senzolo M., Shah V., Shukla A., Tandon P., Tellez L., Thabut D., Thiele M., Trebicka J., Tripathi D., Tsochatzis E., Turco L., Turon F., Valla D., Villanueva C., Wanless I., Yoshiji H., Baveno VII Faculty. Baveno VII – Renewing consensus in portal hypertension. JOURNAL OF HEPATOLOGY. 2022; 76(4)DOI:10.1016/j.jhep.2021.12.022. PMID:35120736. IF:25.700(Q1/1D).
01/01/2022
Viral Culture Confirmed SARS-CoV-2 Subgenomic RNA Value as a Good Surrogate Marker of Infectivity
Bravo, MS, Berengua, C, Marin, P, Esteban, M, Rodriguez, C, del Cuerpo, M, Miro, E, Cuesta, G, Mosquera, M, Sanchez-Palomino, S, Vila, J, Rabella, N, Marcos, MA. Viral Culture Confirmed SARS-CoV-2 Subgenomic RNA Value as a Good Surrogate Marker of Infectivity. JOURNAL OF CLINICAL MICROBIOLOGY. 2022; 60(1)DOI:10.1128/JCM.01609-21. PMID:34669457. IF:9.400(Q1/2D).